156
Views
5
CrossRef citations to date
0
Altmetric
Letter to The Editor

Inhibition by Tranilast of the Synergistic Induction of Degranulation and IL-13 Expression by IL-33 and FcɛRI Cross-linking in Mast Cells

, , MD, PhD & , MD, PhD
Pages 841-843 | Received 29 Dec 2015, Accepted 26 Apr 2016, Published online: 05 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ali Saeedi-Boroujeni, Mohammad-Reza Mahmoudian-Sani, Roohangiz Nashibi, Sheyda Houshmandfar, Sima Tahmaseby Gandomkari & Ali Khodadadi. (2021) Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19. Immunopharmacology and Immunotoxicology 43:3, pages 247-258.
Read now

Articles from other publishers (4)

Tatsuma Kishimoto, Waka Ishida, Isana Nakajima, Ken Fukuda & Kenji Yamashiro. (2022) Aqueous-Deficient Dry Eye Exacerbates Signs and Symptoms of Allergic Conjunctivitis in Mice. International Journal of Molecular Sciences 23:9, pages 4918.
Crossref
Ken Fukuda, Waka Ishida, Tatsuma Kishimoto, Isana Nakajima, Yusaku Miura, Tamaki Sumi & Kenji Yamashiro. (2022) Role of Damage-Associated Molecular Patterns (DAMPs/Alarmins) in Severe Ocular Allergic Diseases. Cells 11:6, pages 1051.
Crossref
Khashayar Zafar-Mohammadi, Javad Poursamimi & Mahdi Atabaki. (2022) NLRP3 inflammasome activation and its inhibitory drugs in connection with COVID-19 infection. European Journal of Inflammation 20, pages 1721727X2211309.
Crossref
Nir Erdinest, Naomi London & Abraham Solomon. (2020) Chemokines in allergic conjunctivitis. Current Opinion in Allergy & Clinical Immunology 20:5, pages 516-527.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.